We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+5.8%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$243M
AUM Growth
-$8.83M
(-3.5%)
Cap. Flow
-$21M
Cap. Flow
% of AUM
-8.67%
Top 10 Holdings %
Top 10 Hldgs %
68.56%
Holding
127
New
18
Increased
18
Reduced
12
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Calumet Specialty Products
CLMT
|
+$6.99M |
| 2 |
FTAI Aviation
FTAI
|
+$4.2M |
| 3 |
Upland Software
UPLD
|
+$4.19M |
| 4 |
Smith & Wesson
SWBI
|
+$3.62M |
| 5 |
Meta Platforms (Facebook)
META
|
+$3.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$33.3M |
| 2 |
Pfizer
PFE
|
+$12.4M |
| 3 |
Microsoft
MSFT
|
+$6.16M |
| 4 |
RXDX
Ignyta, Inc.
RXDX
|
+$1.81M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$1.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.53% |
| 2 | Technology | 8.11% |
| 3 | Industrials | 7.13% |
| 4 | Financials | 7.01% |
| 5 | Energy | 6.35% |
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q1 2018 Portfolio in Review
As of Q1 2018, David M. Knott held 127 positions worth $243M, down 3.5% from $251M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
David M. Knott withdrew a net $21M in Q1 2018, closing 20 positions and reducing 12 holdings. Its most notable exit was Ignyta, Inc., an estimated $1.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 65% a quarter earlier, followed by Technology and Industrials.
Against the trend, David M. Knott opened a new position in Calumet Specialty Products worth $6.67M.
- David M. Knott's largest Q1 2018 buy was Calumet Specialty Products: 945,558 shares worth $6.67M.
- David M. Knott added most to FTAI Aviation in Q1 2018, an estimated $4.2M increase.
- David M. Knott's biggest Q1 2018 reduction was Ligand Pharmaceuticals, cutting an estimated $33.3M.
- David M. Knott fully exited Ignyta, Inc. in Q1 2018, selling an estimated $1.81M.
- David M. Knott's ten largest holdings make up 69% of its $243M portfolio in Q1 2018.
- David M. Knott opened 18 new positions and closed 20 in Q1 2018.
- David M. Knott's portfolio value fell 3.5% quarter-over-quarter to $243M.
Based on David M. Knott's 13F filing for Q1 2018, filed 11 May 2018.